ALTANA

H1/Q2 2007 Reporting

Until the end of the business year 2006, the ALTANA Group consisted of the two divisions ALTANA Chemie and ALTANA Pharma as well as the ALTANA AG holding company. ALTANA Pharma was sold effective December 31, 2006. As a consequence, reported figures for the year 2006 will be adjusted to reflect the continuing operations (ALTANA Chemie and ALTANA AG holding).

In preparation for the reporting of H1/Q2 2007 results on August 8, 2007 we herewith would like to provide you with the corresponding comparable basis for H1/Q2 2006.


H1/Q2 2006 – CONTINUING OPERATIONS:

(in Mio. €)

H1/2006

Q2/2006

Sales

659.0

334.5

Earnings before interest, taxes,
depreciation and amortization (EBITDA)

103.1

53,1

EBITDA margin

15.6%

15,8%

Earnings before interest and taxes (EBIT)

64.4

34.1

EBIT margin

9.8%

10.2%

Earnings before taxes (EBT)

62.7

33.6

EBT margin

9.5%

10.1%

Net income (EAT)

39.8

21,3

EAT margin

6.0%

6.4%

Earnings per share (EPS),

0,29

0.15

R&D expenditure

33.5

16,9

Capital expenditure

31,5

17.0


In case of any questions, please do not hesitate to contact us.